These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8841316)

  • 21. Primary antiphospholipid syndrome is not associated with activated protein C resistance caused by factor V Arg 506 -->Gln mutation.
    Biousse V; Piette JC; Frances C; Bletry O; Papo T; Tournier-Lasserve E; Duchemin J; Aiach M
    J Rheumatol; 1995 Jun; 22(6):1215. PubMed ID: 7674266
    [No Abstract]   [Full Text] [Related]  

  • 22. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thrombosis--the interaction of genes and environment.
    Bertina RM; Rosendaal FR
    N Engl J Med; 1998 Jun; 338(25):1840-1. PubMed ID: 9632453
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor V Leiden mutation and completed stroke.
    Catto A; Carter A; Grant PJ
    Stroke; 1996 Mar; 27(3):573. PubMed ID: 8610336
    [No Abstract]   [Full Text] [Related]  

  • 26. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.
    Braun A; Müller B; Rosche AA
    Hum Genet; 1996 Feb; 97(2):263-4. PubMed ID: 8566967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to activated protein C: a common inherited cause of venous thrombosis.
    Gillespie DL; Carrington LR; Griffin JH; Alving BM
    Ann Vasc Surg; 1996 Mar; 10(2):174-7. PubMed ID: 8733870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis--a case report.
    Pugliese D; Nicoletti G; Andreula C; Ciccone M; Triggiani G
    Angiology; 1998 May; 49(5):399-401. PubMed ID: 9591532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective thrombolysis in a newborn with bilateral renal venous and cerebral thrombosis and heterozygous APC resistance.
    Klinge J; Scharf J; Rupprecht T; Böswald M; Hofbeck M
    Nephrol Dial Transplant; 1998 Dec; 13(12):3205-7. PubMed ID: 9870492
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.
    Hellgren M; Svensson PJ; Dahlbäck B
    Am J Obstet Gynecol; 1995 Jul; 173(1):210-3. PubMed ID: 7631684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral venous thrombosis in hereditary protein C deficiency.
    Vieregge P; Schwieder G; Kömpf D
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):135-7. PubMed ID: 2709030
    [No Abstract]   [Full Text] [Related]  

  • 39. [Retinal vein occlusion and resistance to activated protein C].
    Scat Y; Morin Y; Morel C; Haut J
    J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.